UK

Usha Kumari

Active Director Director DIN 06901192
DIN 06901192 First appointment Jul 2014 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2014
Shareholding value •••• Premium profile

About Usha Kumari

Data last updated:

Usha Kumari is a Director at Addvet Nutraceuticals Private Limited (since 2014). The company operates in Chemicals. Addvet Nutraceuticals Private Limited reported revenue of ₹61.8 Lakh (FY 2024).

DIN 06901192
Primary Designation Director
Industry Chemicals
First Appointment 03 Jul 2014
Oldest Company Age 12 yrs
Largest company Addvet Nutraceuticals Private Limited · ₹61.8 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Jul 20142014₹61.8 Lakh (FY 2024)Active

Board colleagues of Usha Kumari

NameDINCompanyDesignation
Sumit Kumar06901077Addvet Nutraceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Addvet Nutraceuticals Private Limited
Premium access

Shareholding and investment profile for Usha Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Usha Kumari

Usha Kumari currently holds 1 directorship: Addvet Nutraceuticals Private Limited (Director, since 03 Jul 2014, revenue ₹61.8 Lakh (FY 2024)).

Usha Kumari was first appointed on 03 Jul 2014 as Director at Addvet Nutraceuticals Private Limited.

The current boards of Usha Kumari's companies include Sumit Kumar (Addvet Nutraceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available